Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2023
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer, Emanuela Gentile, Andrew W Hahn, Jian H Song, et al.
The In Vitro Activity of Delafloxacin and Comparator Agents Against Bacterial Pathogens Isolated From Patients With Cancer, Bahgat Gerges, Kenneth Rolston, Samuel A Shelburne, et al.
Segmentation of Acute Stroke Infarct Core Using Image-Level Labels on CT-Angiography, Luca Giancardo, Arash Niktabe, Laura Ocasio, et al.
Impact of Common Vitamin D-Binding Protein Isoforms on Supplemental Vitamin D3 and/or Calcium Effects on Colorectal Adenoma Recurrence Risk: A Secondary Analysis of a Randomized Clinical Trial, David Corley Gibbs, Elizabeth L Barry, Veronika Fedirko, et al.
Individual Differences in Late Positive Potential Amplitude and Theta Power Predict Cue-Induced Eating, Kyla D Gibney, George Kypriotakis, and Francesco Versace
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504, Maura L Gillison, Robert L Ferris, Jonathan Harris, et al.
The Landscape of Immunotherapy for Retroperitoneal Sarcoma, Alicia A Gingrich, Elise F Nassif, Christina L Roland, et al.
An F-Ratio-Based Method for Estimating the Number of Active Sources in MEG, Amita Giri, John C Mosher, Amir Adler, et al.
Sepsis Exacerbates Alzheimer’s Disease Pathophysiology, Modulates the Gut Microbiome, Increases Neuroinflammation and Amyloid Burden, Vijayasree V Giridharan, Celso S G Catumbela, Carlos Henrique R Catalão, et al.
Circulating Neutrophils and Tumor-Associated Myeloid Cells Function as a Powerful Biomarker for Response to Chemoradiation in Locally Advanced Cervical Cancer, Olsi Gjyshi, Adam Grippin, Lauren Andring, et al.
Exploiting Metabolic Vulnerabilities After Anti-vegf Antibody Therapy in Ovarian Cancer, Deanna Glassman, Mark S Kim, Meredith Spradlin, et al.
Concurrent Intrathecal and Intravenous Nivolumab in Leptomeningeal Disease: Phase 1 Trial Interim Results, Isabella C Glitza Oliva, Sherise D Ferguson, Roland Bassett, et al.
Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia, Christina Glytsou, Xufeng Chen, Emmanouil Zacharioudakis, et al.
Radiolabeled Nanomaterial for Cancer Diagnostics and Therapeutics: Principles and Concepts, Muskan Goel, Yuri Mackeyev, and Sunil Krishnan
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma, Betul Gok Yavuz, Saumil Datar, Shadi Chamseddine, et al.
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma, Betul Gok Yavuz, Saumil Datar, Shadi Chamseddine, et al.
The P323L Substitution in the SARS-CoV-2 Polymerase (NSP12) Confers a Selective Advantage During Infection, Hannah Goldswain, Xiaofeng Dong, Rebekah Penrice-Randal, et al.
Machine Learning-Based Routine Laboratory Tests Predict One-Year Cognitive and Functional Decline in a Population Aged 75+ Years, Karina Braga Gomes, Ramon Gonçalves Pereira, Alexandre Alberto Braga, et al.
Two Structurally Defined Aβ Polymorphs Promote Different Pathological Changes in Susceptible Mice, Ruben Gomez-Gutierrez, Ujjayini Ghosh, Wai-Ming Yau, et al.
TLR5 Agonists Enhance Anti-Tumor Immunity and Overcome Resistance to Immune Checkpoint Therapy, Caleb Gonzalez, Sarah Williamson, Seth T Gammon, et al.
Peripheral Eosinophil Trends and Clinical Outcomes After Non-traumatic Subarachnoid Hemorrhage, Hugo Gonzalez Gomez, Jude P J Savarraj, Atzhiry S Paz, et al.
Mechanosensitive Membrane Proteins: Usual and Unusual Suspects in Mediating Mechanotransduction, Miriam B Goodman, Elizabeth S Haswell, and Valeria Vásquez
Structural Basis of a Transcription Pre-initiation Complex on a Divergent Promoter, Jose J Gorbea Colón, Leon Palao, Shin-Fu Chen, et al.
A Novel Comorbidity Score for Older Adults With Non-Hodgkin Lymphoma: The 3-Factor Risk Estimate Scale, Max J Gordon, Zhigang Duan, Hui Zhao, et al.
Long-Term Outcomes in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Focus on Hypertension and Cardiovascular Toxicity, Max J Gordon, Jade E Jones, Binsah George, et al.